BrilliA vs Ping An Biomedical
BRIA and PASW side by side, both in apparel and other finished products made from fabrics and similar materials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BRIA and PASW compare
BrilliA grew revenue faster over the last twelve months (−23.1% versus −61.0% for Ping An Biomedical).
BrilliA keeps more of each dollar of sales as profit, with a net margin of −0.03% compared with −37.6% at Ping An Biomedical.
Ping An Biomedical scores higher on the StockData Score (2 against 1 for BrilliA), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BRIA | PASW |
|---|---|---|
| Size and price | ||
| Share price | $1.35 | $1.53 |
| Change, 1 year | −25.0% | −94.1% |
| Beta (5Y) | 0.46 | – |
| Employees | 224 | 7 |
| StockData Score | ||
| Total score | 1 | 2 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −23.1% (better) | −61.0% |
| Net income growth (TTM) | −101% | – |
| EPS growth (TTM) | −108% | – |
| Profitability | ||
| Gross margin | 14.3% (better) | 2.8% |
| Operating margin | – | −43.1% |
| Net margin | −0.03% (better) | −37.6% |
| FCF margin | 0.34% | – |
| Return on equity | – | −38.6% |
| Return on invested capital | – | −29.2% |
| Financial health | ||
| Debt / equity | – | 0.13 |
| Interest coverage | – | −47.9× |
| Current ratio | 2.23 | 2.54 (better) |
| Piotroski F-score | 3 | 3 |
| Ownership | ||
| Held by institutions | 0.00% | – |
| Held by insiders | 72.9% | 10.3% |
| Short interest, % of float | 0.15% | – |
Go deeper
- BRIA stock overview
- BRIA income statement
- BRIA valuation and score
- PASW stock overview
- PASW income statement
- PASW valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.